RUA Life Sciences Submits FDA Application for Vascular Grafts
03 Novembre 2021 - 10:48AM
Dow Jones News
By Sabela Ojea
RUA Life Sciences PLC said Wednesday that the RUA Vascular
business has submitted its premarket notification for a range of
polymerically sealed vascular grafts to the U.S. Food and Drug
Administration.
The developer of polymer materials for medical devices said the
submission follows an introduction of the RUA graft at the recent
annual meeting of the European Association for Cardio-Thoracic
Surgery, held in Barcelona, Spain.
Shares at 0912 GMT were up 10.00 pence, or 6.6%, at 161.50
pence.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
November 03, 2021 05:33 ET (09:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Aortech (LSE:AOR)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Aortech (LSE:AOR)
Storico
Da Mag 2023 a Mag 2024
